Showing results (331-340 of 372) with videos related to
Sort By:
Pageof 38
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2011
Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatmentLeslie S Kurtzberg, Stephanie Roth, Roy Krumbholz, et al.Molecular Cancer Therapeutics|October 15, 2008
Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitorsLeslie S Kurtzberg, Traci Battle, Cecile Rouleau, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2004
Report from the society for biological therapy and vascular biology faculty of the NCI workshop on angiogenesis monitoringDonald M McDonald, Beverly A Teicher, William Stetler-Stevenson, et al.Molecular Cancer Therapeutics|April 3, 2021
F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCydJoel Morris, Donn G Wishka, Omar D Lopez, et al.Journal of the National Cancer Institute|October 19, 2014
Combining targeted agents with modern radiotherapy in soft tissue sarcomasPhilip Wong, Peter Houghton, David G Kirsch, et al.Journal of the National Cancer Institute|June 2, 2016
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA ExpressionEric Polley, Mark Kunkel, David Evans, et al.Experimental Hematology|February 6, 2024
In vivo activity of the second-generation proteasome inhibitor ixazomib against pediatric T-cell acute lymphoblastic leukemia xenograftsJoanna Randall, Kathryn Evans, Ben Watts, et al.Cancer Research|November 3, 2004
Alterations in vascular gene expression in invasive breast carcinomaBelinda S Parker, Pedram Argani, Brian P Cook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinomaCecile Rouleau, Maritza Curiel, William Weber, et al.Cancer Chemotherapy and Pharmacology|July 24, 2012
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugatesDiego A Gianolio, Cecile Rouleau, William E Bauta, et al.Pageof 38